Search hospitals > Pennsylvania > Lebanon
Sechler Family Cancer Center
Claim this profileLebanon, Pennsylvania 17042
Global Leader in Parotid Gland Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
72 reported clinical trials
9 medical researchers
Summary
Sechler Family Cancer Center is a medical facility located in Lebanon, Pennsylvania. This center is recognized for care of Parotid Gland Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Breast cancer and other specialties. Sechler Family Cancer Center is involved with conducting 72 clinical trials across 114 conditions. There are 9 research doctors associated with this hospital, such as Amit B. Shah, Chanh T. Huynh, Dan Sotirescu, and Joseph Kannarkatt.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Amit B. ShahWellSpan Health-York Cancer Center3 years of reported clinical research
Studies Prostate Cancer
Studies Breast Cancer
23 reported clinical trials
65 drugs studied
Chanh T. HuynhAdams Cancer Center2 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
38 drugs studied
Dan SotirescuEphrata Cancer Center6 years of reported clinical research
Studies Parotid Gland Cancer
Studies Lung Cancer
11 reported clinical trials
28 drugs studied
Joseph KannarkattWellSpan Medical Oncology and Hematology4 years of reported clinical research
Studies Lung Cancer
Studies Breast Cancer
7 reported clinical trials
31 drugs studied
Clinical Trials running at Sechler Family Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Parotid Gland Cancer
Small Cell Lung Cancer
Breast cancer
Prostate Adenocarcinoma
Prostatic Neoplasm
Pancreatic Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sechler Family Cancer Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.